182 related articles for article (PubMed ID: 10338267)
1. Uses of progesterone in clinical practice.
Warren MP; Shantha S
Int J Fertil Womens Med; 1999; 44(2):96-103. PubMed ID: 10338267
[TBL] [Abstract][Full Text] [Related]
2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
3. [Non-oral administration of progesterone: experiences and possibilities of the transvaginal route].
de Ziegler D; Seidler L; Schärer E; Bouchard P
Praxis (Bern 1994); 1995 Feb; 84(5):127-33. PubMed ID: 7878312
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral micronized progesterone in the treatment of luteal phase defects.
Frishman GN; Klock SC; Luciano AA; Nulsen JC
J Reprod Med; 1995 Jul; 40(7):521-4. PubMed ID: 7473442
[TBL] [Abstract][Full Text] [Related]
5. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
Cicinelli E
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone.
Zarutskie PW; Phillips JA
Fertil Steril; 2009 Jul; 92(1):163-9. PubMed ID: 19362303
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P
Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of the efficacy, side effects and patient convenience between vaginal and rectal administration of Cyclogest(®) when used for luteal phase support in ICSI treatment.
Aghsa MM; Rahmanpour H; Bagheri M; Davari-Tanha F; Nasr R
Arch Gynecol Obstet; 2012 Oct; 286(4):1049-54. PubMed ID: 22714063
[TBL] [Abstract][Full Text] [Related]
9. Parenteral administration of progestins for hormonal replacement therapy.
Nath A; Sitruk-Ware R
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):88-96. PubMed ID: 19340703
[TBL] [Abstract][Full Text] [Related]
10. Vaginal micronized progesterone in continuous hormone replacement therapy. A prospective randomized study.
Ferrero S; Gerbaldo D; Fulcheri E; Cristoforoni P
Minerva Ginecol; 2002 Dec; 54(6):519-30. PubMed ID: 12432337
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
Simunic V; Tomic V; Tomic J; Nizic D
Fertil Steril; 2007 Jan; 87(1):83-7. PubMed ID: 17081536
[TBL] [Abstract][Full Text] [Related]
12. Oral micronized progesterone.
de Lignières B
Clin Ther; 1999 Jan; 21(1):41-60; discussion 1-2. PubMed ID: 10090424
[TBL] [Abstract][Full Text] [Related]
13. [Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone].
Pouly JL; Bassil S; Frydman R; Hédon B; Nicollet B; Prada Y; Antoine JM; Zambrano R; Donnez J
Contracept Fertil Sex; 1997; 25(7-8):596-601. PubMed ID: 9410372
[TBL] [Abstract][Full Text] [Related]
14. [Preclinical research and development of norethisterone].
Mcguire JL; Hahn DW; Philipps A
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
[TBL] [Abstract][Full Text] [Related]
15. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments.
Tavaniotou A; Smitz J; Bourgain C; Devroey P
Hum Reprod Update; 2000; 6(2):139-48. PubMed ID: 10782572
[TBL] [Abstract][Full Text] [Related]
16. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
17. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
Kleinstein J;
Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
[TBL] [Abstract][Full Text] [Related]
19. Routes of delivery for progesterone and progestins.
Sitruk-Ware R
Maturitas; 2007 May; 57(1):77-80. PubMed ID: 17368973
[TBL] [Abstract][Full Text] [Related]
20. Progesterone administration in patients with absent ovaries.
Devroey P; Palermo G; Bourgain C; Van Waesberghe L; Smitz J; Van Steirteghem AC
Int J Fertil; 1989; 34(3):188-93. PubMed ID: 2567713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
